Platelet-rich plasma (PRP) has gained increasing attention in podiatry and sports medicine as a minimally invasive regenerative treatment for chronic musculoskeletal conditions of the foot and ankle. By utilizing concentrated platelets and growth factors derived from the patient’s own blood, PRP aims to support tissue healing, modulate inflammation, and improve pain and function in select chronic conditions.
Although PRP has shown promising results in certain chronic foot and ankle conditions, evidence remains variable across indications. Current literature most strongly supports the use of PRP in chronic plantar fasciitis, but researchers still need further evidence to better define optimal indications, preparation protocols, and long-term clinical outcomes.
How Is PRP Used in Podiatry?
Clinicians create platelet-rich plasma by centrifuging a patient’s blood to concentrate platelets and growth factors. Once injected into the target tissue, PRP may help stimulate healing responses and tissue regeneration.
PRP injections are typically performed in an outpatient setting and may be incorporated into treatment plans for chronic soft tissue and tendon-related conditions.
The procedure generally involves:
- Blood collection from the patient
- Centrifugation to isolate platelet-rich plasma
- Guided injection into the affected tissue
- Post-procedure rehabilitation and activity modification as needed
Clinical outcomes may vary depending on preparation protocols, including platelet concentration, leukocyte content, and activation methods.
Common Applications of PRP in Podiatry
- Chronic Plantar Fasciitis – The most supported indication for PRP in podiatry, particularly in patients with symptoms lasting longer than 3–6 months who have failed conservative treatment. Studies suggest improved long-term pain relief and function compared with corticosteroid injections.
- Achilles Tendinopathy – Researchers continue to investigate PRP as a regenerative treatment option for chronic tendon degeneration. While some studies report promising outcomes, the overall evidence remains mixed and further research is needed.
- Chronic Tendon and Soft Tissue Disorders – Clinicians have explored PRP for tendon degeneration, ligament pathology, and chronic soft tissue injuries of the foot and ankle. Although early findings show potential, current clinical evidence remains limited.
- Post-Surgical and Chronic Foot Pain – Emerging applications include tissue healing support and chronic postoperative pain management, but evidence is still evolving.
Clinical Benefits and Considerations
Potential benefits of PRP include:
- Minimally invasive regenerative treatment option
- Use of autologous biologic material
- Favorable safety profile with low complication rates
- Potential long-term improvement in pain and function in chronic plantar fasciitis
- Ultrasound-guided precision targeting of soft tissue pathology
Clinical considerations include:
- Variability in PRP preparation protocols
- Inconsistent evidence across different foot and ankle conditions
- Outcomes may depend on chronicity and severity of pathology
- Multiple treatments or adjunct rehabilitation may be required
Evidence Supporting PRP in Podiatry
A study titled evaluated PRP treatment across multiple foot and ankle conditions in patients who had not responded to physical therapy. Key findings included:
- 75% of patients increased activity levels following PRP treatment.
- 83% did not pursue surgical intervention after PRP.
- 23% reported complete pain resolution.
- 77% considered PRP worth the out-of-pocket cost.
A comprehensive review titled “The use of platelet-rich plasma in pathologies of the foot and ankle: A comprehensive review of the recent literature” evaluated PRP across a variety of foot and ankle disorders. Key findings included:
- PRP demonstrated promising results for conditions such as plantar fasciitis, Achilles tendinopathy, and ankle osteoarthritis.
- Studies reported improvements in pain and functional outcomes.
- Future research should establish standardized treatment protocols through additional high-quality studies.
A randomized controlled trial titled “Efficacy of platelet rich plasma injection as a combined modality in reducing pain and improving functional outcome in plantar fasciitis” evaluated PRP for chronic plantar fasciitis. Key findings included:
- PRP significantly reduced heel pain.
- Patients experienced improved foot function and daily activity.
- Imaging findings suggested improved plantar fascia healing following treatment.
Recent evidence continues to support PRP as a promising regenerative treatment for chronic foot and ankle conditions. Studies have demonstrated improvements in pain, function, activity levels, and the potential to reduce surgical intervention in patients who have not responded to conservative care.
FAQs
Q1: Is ultrasound guidance recommended for PRP injections in podiatry?
Yes. Clinicians commonly use ultrasound guidance to improve injection accuracy and target degenerative soft tissue pathology more precisely during PRP procedures.
Q2: What factors can influence PRP treatment outcomes?
Clinical outcomes may vary depending on several factors, including platelet concentration, leukocyte content, activation method, chronicity of pathology, injection technique, and post-procedure rehabilitation protocols.
Q3: What PRP systems are available for podiatric regenerative procedures?
Systems such as Epimed’s Tropocells® PRP support the efficient preparation of platelet-rich plasma for regenerative medicine applications.
Q4: Can PRP be used alongside other treatments?
PRP may be used as a standalone treatment or as part of a broader care plan. Treatment decisions depend on the patient’s condition, clinical goals, and physician judgment.










